Sarcoidosis in the setting of idiopathic chronic bronchiolitis with airway colonization from P. aeruginosa: Treatment with low-dose macrolides

Internal Medicine

Volumn 47, Issue 6, 2008, Pages 537-542

  Trisolini, Rocco ^a   Cancellieri, Alessandra ^a   Paioli, Daniela ^a   Burzi, Marcellino ^a   Orlandi, Paolo ^a   Patelli, Marco ^a  

^a MAGGIORE HOSPITAL   (Italy)

Author keywords

Bronchiolitis; Bronchoscopy; Diffuse panbronchiolitis; Macrolides; P. aerugnisoa; Sarcoidosis

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; ERYTHROMYCIN; MACROLIDE; OXYGEN; ANTIINFECTIVE AGENT;

AGED; ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BRONCHIOLITIS; BRONCHITIS; BRONCHOSCOPY; CASE REPORT; CHRONIC DISEASE; CLINICAL EXAMINATION; HOSPITAL ADMISSION; HUMAN; LOW DRUG DOSE; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; OUTCOME ASSESSMENT; PATIENT REFERRAL; PSEUDOMONAS AERUGINOSA; SARCOIDOSIS; TREATMENT DURATION; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; GRAM NEGATIVE INFECTION; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; RADIOGRAPHY; RESPIRATORY SYSTEM;

AGED; ANTI-BACTERIAL AGENTS; BRONCHIOLITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MACROLIDES; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY SYSTEM; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41649120844     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0675     Document Type: Article

References (20)

1. Poletti V, Chilosi M, Trisolini R, et al. Idiopathic bronchiolitis mimicking diffuse panbronchiolitis. Sarcoidosis Vasc Diffuse Lung Dis 20: 62-68, 2003.
2. Kadota J, Mukae H, Mizunoe S, et al. Long-term antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis. Intern Med 44: 200-206, 2005.
3. Poletti V, Chilosi M, Casoni G, Colby TV. Diffuse panbronchiolitis. Sarcoidosis Vasc Diffuse Lung Dis 21: 94-104, 2004.
4. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157: 1829-1832, 1998.
5. Gal AA, Koss MN. The pathology of sarcoidosis. Curr Opin Pulm Med 8: 445-451, 2002.
6. Hunninghake GW, Costabel U, Ando M, et al. Statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16: 149-173, 1999.
7. Meier FA. Pseudomonas aeruginosa. In: Pathology of Infectious, Diseases. Connor DH, Chandler FW, Manz HJ, et al, Eds. Appleton & Lange, Stamford, 1997: 647-656.
8. Pseudomonas aeruginosa. In: Non-neoplastic disorders of the lower respiratory tract. Travis WD, Colby TV, Koss MN, Rosado-de-Christenson ML, Muller NL, King TE, Eds. AFIP, ARP, 2002; 550-553.
9. McGrath DS, Goh N, Foley PJ, du Bois RM. Sarcoidosis: genes and microbes - soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 18: 149-164, 2001.
10. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 361: 1111-1118, 2003.
11. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170: 1324-1330, 2004.
12. Takahashi T, Suga M, Matsukawa A, et al. Erythromycin attenuates an experimental model of chronic bronchiolitis via augmenting monocyte chemoattractant protein-1. Eur Respir J 17: 360-367, 2001.
13. Wozniak DJ, Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 125: 62 S-69S, 2004.
14. Schultz W. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemother 54: 21-28, 2004.
15. Semmler A, Whitchurch CB, Mattick JS. A re-examination of twitching motility in Pseudomonas aeruginosa. Microbiology 145: 2863-2873, 1999.
16. Sheth HB, Lee KK, Wong WY, et al. The pili of Pseudomonas aeruginosa strains PAK and PAO bind specifically to the carbohydrate sequence bGalNAc (1-4) beta Gal found in glycosphingolipids asialo-GM1 and asialo-GM2. Mol Microbiol 11: 715-723, 1994.
17. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322, 1999.
18. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Muller-Quernheim J. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL 2R are prognostic markers. Am J Respir Crit Care Med 156: 1586-1592, 1997.
19. Baughman RP, Keeton D, Lower EE. Relationship between interleukin-8 and neutrophils in the BAL fluid of sarcoidosis. Sarcoidosis 11: S217-S220, 1994.
20. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE. Release of tumor necrosis factor by alveolar macrophages of patients with sarocidosis. J Lab Clin Med 115: 36-42, 1990.